Evidence for improved survival with treatment of homozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evidence for improved survival with treatment of homozygous familial hypercholesterolemia

Published:2020-06-09 Issue:4 Volume:31 Page:176-181
ISSN:0957-9672
Container-title:Current Opinion in Lipidology
language:en
Short-container-title:

Author:

Bélanger Alexandre M.,Akioyamen Leo,Alothman Latifah,Genest Jacques

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Genetics,Molecular Biology,Endocrinology, Diabetes and Metabolism

Reference24 articles.

1. Angina pectoris in hereditary xanthomatosis;Müller;Arch Intern Med,1939

2. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

3. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel;Santos;Lancet Diabetes Endocrinol,2016

4. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy;Raal;Circulation,2011

5. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: the Sino-Roman Study;Stefanutti;J Clin Lipidol,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy;European Heart Journal;2024-06-10

2. SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning;IEEE/ACM Transactions on Computational Biology and Bioinformatics;2024-03

3. Phenotypic homozygous familial hypercholesterolemia successfully treated with proprotein convertase subtilisin/kexin type 9 inhibitors;Clinical Case Reports;2024-02

4. Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy;International Journal of Molecular Sciences;2024-01-29

5. Editorial comments: focus on lipid lowering and weight loss role in cardiovascular prevention;European Journal of Preventive Cardiology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3